TorMagnus Pharmaceuticals Company
TorMagnus Pharmaceuticals is a drug discovery firm dedicated to discovering treatments for Peroxisomal disorders.
Investors Number:
1.0
Total Funding:
500000.0
Technology:
['BioTech & HealthTech']
Industry:
Medical BioTech
Founded Date:
2022-05-01
Headquarters:
San Francisco, California, United States
Last Funding Date:
2023-04-05
Last Funding Type:
Pre-Seed
Investor Type:
contact@tormagnuspharma.com
Funding Status:
Seed